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Abstract: Boraformylation of allenes proceeds using B2(pin)2 and a 
formate ester as boron and formyl sources, respectively, in the 
presence of a copper catalyst. The reaction selectively affords the 
corresponding -boryl-,-unsaturated aldehydes in good-to-high 
yields. In addition, silaformylation of allenes is achieved with a 
formate ester using PhMe2Si–B(pin) as a silicon source. 
Organoboronic acids and esters are versatile boryl 
functionalities in organic synthesis, especially for cross coupling 
reactions.[1] Thus, various preparation methods of organoboron 
compounds have been explored, typically hydroboration of 
carbon-carbon (C–C) unsaturated bonds[2] and reactions of 
boron electrophiles with organolithium or Grignard reagents.[1a] 
Being more common in organic synthesis, silyl functionalities 
achieve a variety of highly efficient transformations.[3]  
Simultaneous incorporation of two different functionalities onto 
C–C unsaturated bonds is one of the most capable 
methodologies for the preparation of complex molecules. In 
particular, allenes (1,2-dienes) are valuable reaction platforms 
owing to their structurally diverse array of products.[4] However, 
this dual functionalization of allenes provides a range of regio- 
and stereoisomers. Thus, selective formation of desired 
products is a highly important task. 
Herein, we report on boraformylation of allenes via 
simultaneous incorporation of boryl and formyl functionalities 
onto the C–C double bonds of allenes to afford -boryl-,-
unsaturated aldehydes with high regioselectivity (Scheme 1a). 
The formyl moiety is a potent functionality, which can be further 
converted to useful compounds. It is frequently provided via 
oxidation of primary alcohols,[5] reduction of carboxylic acids,[5] 
and, in industry, via the hydroformylation of alkenes under 
CO/H2 pressure.
[6] We found that boraformylation of allenes was 
achieved by employing B2(pin)2 and a formate ester as boron 
and formyl sources, respectively, in the presence of a copper 
catalyst. Formate esters were used as a formyl source in 
Claisen-type condensation reactions.[7] To the best of our 
knowledge, this is the first report on the boraformylation of 
unsaturated substrates. Furthermore, silaformylation of allenes 
was achieved for the first time, by employing PhMe2Si–B(pin) as 
a silicon source along with a formate ester (Scheme 1b). 
 
Scheme 1. Boraformylation and Silaformylation of Allenes. 
First, the reaction of 3-methyl-1,2-nonadiene (1a), B2(pin)2, 
and hexyl formate was conducted at 50 °C by employing 3.0 
mol % of CuOAc and 4.0 mol % of a ligand in toluene (Table 
1).[8] Impressively, the steric effect of the ligands strongly 
affected the reaction. PPh3, dppe, xantphos, and dppbz
[9] (Figure 
1) were ineffective in the catalytic reaction, yielding the desired 
-boryl-,-unsaturated aldehyde (2a) in only trace amounts 
(entries 1–4). However, Xy-dppbz produced 2a in 9% yield 
(entry 5). Finally, DTB-dppbz[10] and DTBM-dppbz ligands 
selectively afforded 2a in 99% and 96% yields, respectively 
(entries 6 and 7). As for N-heterocyclic carbene (NHC) ligands, 
IPr gave 2a in 32% yield (entry 8), whereas IMes did not 
produce this compound (entry 9). Benzyl formate (in place of 
hexyl formate) successfully afforded 2a in 80%. yield (entry 10), 
although utilization of phenyl formate considerably decreased 
the yield (entry 11). 
 
Figure 1. Structure of Ligands. 
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Table 1. Ligand Effect on the Cu-catalyzed boraformylation of 1a
[a]
 
 
Entry Ligand 
Formate  
 R= 
Yield 
[%]
[b]
 
1 PPh3 C6H13 trace 
2 dppe  C6H13 2 
3 xantphos C6H13 trace 
4 dppbz C6H13 trace 
5 Xy-dppbz C6H13 9 
6 DTB-dppbz C6H13 99 
7 DTBM-dppbz C6H13 96 
8
[c]
 IPrCuCl/tBuOK  C6H13 32 
9
[d]
 IMesCuCl/tBuOK  C6H13 0 
10 DTBM-dppbz PhCH2 80 
11
 
DTBM-dppbz Ph 31 
[a] Conditions: 1a (0.30 mmol), B2(pin)2 (0.36 mmol, 1.2 equiv), formate (0.33 
mmol, 1.1 equiv), CuOAc (3.0 mol %), ligand (4.0 mol %), in toluene (0.45 mL) 
at 50 °C for 6 h. [b]
 
Determined by GC. [c]
 
A mixture of IPrCuCl (3.0 mol %) 
and tBuOK (10 mol %) was used. [d] A mixture of IMesCuCl (3.0 mol %) and 
tBuOK (10 mol %) was used.  
 
 
With DTBM-dppbz as the ligand, various allenes were 
employed as substrates under optimal reaction conditions (Table 
2). Thus, 1,1-dialkyl-substituted allenes (1a–d) provided the 
corresponding -boryl-,-unsaturated aldehydes (2a–d) in good 
to high isolated yields (entries 1–4). In some cases, the addition 
of sodium laurate[11] (20 mol %) increased the catalytic activity. 
Actually, 1e afforded the corresponding product (2e) in 78% 
isolated yield (entry 5) as compared to 65% GC yield in the 
absence of sodium laurate. With sodium laurate, allenes bearing 
several functionalities such as terminal olefins (1e), Cl-C(sp2)(1f), 
I-C(sp2)(1g), silyloxy (1h), acetal (1i), ester (1j), and carbamate 
(1k) provided the corresponding products (2e–k) in moderate-to-
good yields (entries 5–11). As for mono-substituted allenes, 4,4-
dimethyl-1,2-hexadiene (1l) did not afford the corresponding 
boraformylation products, even after full consumption.  
The present procedure was amenable to a gram-scale 
reaction. Thus, starting from 0.83 g (6.0 mmol) of 1a, 1.3 g of 2a 
was obtained in 72% yield (Scheme 2a). Suzuki–Miyaura 
coupling[1a] of 2a with 4-tert-butyliodobenzene smoothly afforded 
the product in 83% isolated yield (Scheme 2b). Coupling with -
bromostyrene also provided the corresponding diene in 58% 
yield (Scheme 2c). Horner-Wadsworth-Emmons reaction[12] of 2a 
gave the olefinated product in a high isolated yield (Scheme 2d). 
Formate esters, especially aryl formates, are known to 
decompose to CO,[13] thereby offering the opportunity to afford 
the boraformylation with the in situ CO evolved. However, hexyl 
formate did not convert upon removing both B2(pin)2 and 1a from 
entry 1, Table 2. Furthermore, no boraformylation product (2a) 
was obtained (Eq 1) upon replacement of hexyl formate with a  
 
 
 
 
Table 2. Boraformylation of Various Allenes
[a]
 
 
Entry Allene 1 Product 2 Yield [%]
[b]
 
 
[a] Conditions of boraformylation: 1 (0.30 mmol), B2(pin)2 (0.36 mmol, 1.2 equiv), 
hexyl formate (0.33 mmol, 1.1 equiv), CuOAc (3.0 mol %), DTBM-dppbz (4.0 
mol %), in toluene (0.45 mL) at 50 °C for 6 h. [b] 
 
Isolated yield of 2. [c] For 16 h. 
 
[d] Sodium laurate (20 mol %) was added.  
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Scheme 2. Derivatization of Boraformylation Product 
mixture of CO (1 atm) and hexanol. Thus, CO was not involved 
in the present boraformylation of allenes. 
In the case of silaformylation (silylformylation)[14] of C–C 
unsaturated bonds, Matsuda et al. reported the Rh-catalyzed 
reaction of alkynes employing hydrosilanes under carbon 
monoxide (CO) pressure (Eq 2) . [ 1 4 a ,b ]  Intramolecular 
silaformylation of alkenes also proceeded under CO (1,000 
 
 
 
psi).[14h] However, there is no precedent for silaformylation of 
allenes. Silaformylation of allenes was found to proceed by 
employing a silylborane and a formate ester as silyl and formyl 
sources, respectively, in the presence of a copper catalyst 
(Scheme 1b). Note that toxic CO was not required in the present 
silaformylation. When the reaction of 1b with PhMe2Si–B(pin) 
and hexyl formate was conducted in THF at 60 °C, the 
silaformylation product (3b) was obtained in 91% GC and 86% 
isolated yields (Scheme 3a). Less bulky ligands such as Xy-
dppbz and dppbz were not effective (Scheme 3b and c), which is 
in good agreement with the ligand effect observed in the 
boraformylation (Table 1). 
 
Scheme 3. Ligand Effect on Silaformylation. Reaction conditions: Reaction 
conditions, 1b (0.20 mmol), PhMe2Si–B(pin) (0.24 mmol, 1.2 equiv), hexyl 
formate (0.22 mmol, 1.1 equiv), CuOAc (4.0 mol %), ligand (5.0 mol %), in 
THF (0.20 mL) at 60 °C for 4 h. 
 
[a] By GC analysis. [b] Isolated yield. 
 
Scheme 4. Silaformylation of Various Allenes. Reaction conditions, 1a (0.20 
mmol), PhMe2Si–B(pin) (0.24 mmol), hexyl formate (0.22 mmol), CuOAc (4.0 
mol %), DTBM-dppbz (5.0 mol %), in THF (0.20 mL) at 60 °C for 4 h. Isolated 
yields of 3 were shown. [a] For 15 h. 
Various allenes gave the corresponding -silyl-,-unsaturated 
aldehydes in good to high yields via the silaformylation reaction 
(Scheme 4). Functionalities such as terminal olefin (3e), Cl-
C(sp2) (3f), I-C(sp2) (3g), acetal (3i), and ester (3j) were 
tolerated in the reaction. From the mono-substituted allene (1l), 
the corresponding silaformylation product (3l) was obtained in a 
moderate yield. Gram-scale silaformylation of 1b (4.0 mmol) was 
also amenable and provided 3b (1.0 g) in 95% yield. 
Both the bora- and silaformylation proceeded following similar 
catalytic cycles (Scheme 5). It is known that boryl copper 
species (Ab) is generated by the reaction of B2(pin)2 with Cu 
compounds.[15] Silyl copper species (Asi) is also afforded upon 
reaction of PhMe2Si–B(pin) with copper compounds.
[16] Thus, Ab 
and Asi must be key catalyst species involved in the catalytic 
cycles (step 0). Ab and Asi subsequently add across a terminal 
double bond of an allene (1), generating -boryl (Bb)[17] and -
silyl (Bsi)[18] allylcopper intermediates (step 1). Next, Bb and Bsi 
react with a formate ester at the -position to provide Cb and Csi 
via a six-membered ring transition state (step 2). -Elimination 
from Cb and Csi produces 2 (Y = B(pin)) and 3 (Y = SiMe2Ph) 
extruding alkoxycopper species D (step 3). It has been reported 
that ketones,[17e, 18b] aldehydes,[17e,18b,d] and imines[17f,g] react with 
Bb and Bsi to give the corresponding allylated alcohols and 
amines. In the present reaction, the alkoxy moiety of a formate is 
efficiently removed as an alkoxy-Cu species (D) by copper 
species bearing significantly bulky ligands such as DTBM-dppbz 
and DTB-dppbz. Finally, -bond metathesis of D with B2(pin)2 
and PhMe2Si–B(pin) regenerates the active catalyst species Ab 
and Asi (step 4). 
In conclusion, bora- and silaformylation of allenes were 
developed for the first time. In the case of boraformylation, 
B2(pin)2 was a good boron source, with formate ester as efficient 
formyl sources in the presence of a copper catalyst. The 
corresponding -boryl-,-unsaturated aldehydes were 
selectively obtained in good-to-high yields. In the case of 
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silaformylation, -silyl-,-unsaturated aldehydes were provided 
by employing PhMe2Si–B(pin) as a silicon source with a formate 
ester. Further studies on the reaction mechanism and 
enantioselective reactions are now in progress. 
 
Scheme 5. A Possible Catalytic Cycle.  
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This article is protected by copyright. All rights reserved 
RevSI-ASTY-Tsuji
 
 
 
 
1. Instrumentation and Chemicals     S2 
 
2. Preparation of Materials      S3 
 
3. Experimental Procedures      S7 
 
4. Characterization of the Products     S9 
 
5. NMR Charts       S15 
 
6. References        S43 
 
This article is protected by copyright. All rights reserved 
RevSI-ASTY-Tsuji
 
 
S2 
 
1.  Instrumentation and Chemicals 
Anhydrous THF and toluene were purchased from Kanto Chemical Co., Inc or Wako Pure Chem-
ical Industries Ltd. and further purified by passage through activated alumina under positive argon 
pressure as described by Grubbs et al.[1] Unless otherwise noted, reactions were performed under an 
argon atmosphere using heat-gun-dried glassware on a dual-manifold Schlenk line. 1H and 13C NMR 
spectra were recorded on a JEOL ECX-400P spectrometer or a Bruker AVANCE-500 spectrometer. 
Chemical shift values () are reported in ppm and calibrated to tetramethylsilane (TMS, 0.00 ppm) 
residual protiated solvent (7.26 ppm in CDCl3 or 7.16 ppm in C6D6-d6) for 
1H and to CDCl3 (77.0 ppm) 
or C6D6-d6 (128.0 ppm) for 
13C. IR spectra were recorded on a Shimadzu IRTracer-100 FT-IR Spec-
trometer equipped with a Shimadzu MIRacle A (Ge) Single Reflection HATR. High-resolution mass 
spectra were obtained with a Thermo Fischer Scientific EXACTIVE spectrometer for ESI- and APCI-
HRMS, a Thermo Fischer Scientific LTQ orbitrap XL spectrometer for MALDI-HRMS and a JEOL 
JMS-MS700 spectrometer for EI-HRMS. Elemental analysis was carried out at the Center for Organic 
Elemental Microanalysis, Graduate School of Pharmaceutical Science, Kyoto University. GC analysis 
was carried out using a Shimadzu GC-2014 equipped with a capillary column (GL Sciences InertCap 
5, 0.25 mm  30 m). TLC analyses were performed on commercial glass plates bearing a 0.25 mm 
layer of Merck Silica gel 60F254. Column chromatography was carried out on silica-gel (Kanto N60, 
spherical, neutral, 63–210 m or 40–50 m). In the case of boron-containing products, a boronic-acid-
doped silica-gel (B-silica-gel) was used.[2] Medium pressure liquid chromatography (MPLC) was per-
formed on a Biotage Isorera One with a silica-gel column (Biotage SNAP Ultra 25 g or 10 g, HP-
Sphere 25 μm). Microwave reaction was performed on a Biotage Initiator. . 
Hexyl formate was purified by distillation. B2(pin)2 were purified by recrystallization prior to use. 
Unless otherwise noted, chemicals obtained from commercial suppliers were used without further pu-
rification. 3,5-XydppBz,[3] allenes (1a–d, 1i, 1k, 1h and 1l)[4] and PhMe2Si–B(pin)[5] were synthesized 
according to the literatures.   
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2.  Preparation of Materials 
2-1. Preparation of 1,2-bis[bis(3,5-di-tert-buthylphenyl-4-methoxyphenyl)phosphino]benzene 
(DTBM-dppbz) 
 
To a 20 mL vial were added 4-bromo-2,6-di-tert-butylphenol (8.6 g, 30 mmol), methyl iodide (5.6 
mL, 90 mmol), KOH (3.4 g, 60 mmol), and acetone (6.0 mL). The vial was sealed and stirred at 100 °C 
for 1.5 h under microwave irradiation. After the reaction mixture was cooled to room temperature, 
CH2Cl2 (30 mL) and H2O (30 mL) were added. The organic layer was separated and the aqueous layer 
was extracted with CH2Cl2 (5 mL × 3). The combined organic layer was washed with H2O (10 mL × 
3), dried with Na2SO4, filtered, and then evaporated to dryness. The crude mixture was purified by 
silica-gel column chromatography (eluent: hexane) to give the product as slightly yellow crystals (7.3 
g, 24 mmol, 82%). 1H NMR (500 MHz, CDCl3)δ: 7.33 (s, 2H), 3.67 (s, 3H), 1.40 (s, 18H). 13C NMR 
(125 MHz, CDCl3) : 158.8, 146.0, 129.5, 116.4, 64.4, 35.9, 31.9.  All the resonances in 1H and 13C 
NMR spectra were in good agreement with literature values.6 
 
 
To a 200 mL 2-necked round flask with a dropping funnel was added Mg (1.7 g, 68 mmol) under 
Ar. The apparatus was dried, then evacuated and backfilled with Ar three times. 5-Bromo-1,3-di-tert-
butyl-2-methoxybenzene (10 g, 34 mmol) was added into the dropping funnel. After THF (38 mL) was 
added into the dropping funnel, the THF solution was added dropwise for 15 min keeping the temper-
ature around 35–50 °C. Then, the reaction mixture was stirred at 50 °C for 3 h to afford the corre-
sponding Grignard reagent. To a dried 300 mL 2-necked round flask with a dropping funnel was added 
1,2-bis(dichlorophosphino)benzene (1.6 g, 5.7 mmol) under Ar. Then, THF (7 mL) was added to the 
flask, the Grignard reagent was transferred to the dropping funnel. After the apparatus was cooled to 
–78 °C, the Grignard reagent was added dropwise for 15 min. The reaction mixture was stirred for 18 
h from –78 °C to RT. After all volatile was removed in vacuo, CH2Cl2 (30 mL) and saturated NaHCO3 
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aq. (15 mL) were added to the residue. The organic layer was separated and the aqueous layer was 
extracted with CH2Cl2 (10 mL × 3). The combined organic layer was washed with brine (10 mL × 3), 
dried with MgSO4, filtered, evaporated, and then dried in vacuo. The residue was washed with MeOH 
under supersonic, and the solid was filtered and washed with MeOH. The solid was purified by silica-
gel column chromatography (eluent: CH2Cl2) to give DTBM-dppbz as white solids (4.8 g, 4.7 mmol, 
84%). 1H NMR (500 MHz, C6D6)δ: 7.50–7.42 (m, 10H), 7.00 (dd, J = 5.5, 3.4 Hz, 2H), 3.42 (s, 12H), 
1.38 (s, 72H). 13C NMR (125 MHz, C6D6) : 160.3, 145.7 (t, J = 8.6 Hz), 143.7 (t, J = 3.8 Hz), 134.1 
(t, J = 2.9 Hz), 133.1 (t, J = 11.0 Hz), 132.6 (t, J = 2.9 Hz), 129.0, 128.2 (t, J = 23.8 Hz,), 64.1, 36.1, 
32.4. 31P NMR (202 MHz, C6D6) : –11.5. Anal. Calcd. for C66H96O4P: C, 78.07; H, 9.53. Found: C, 
77.49; H, 9.38. 
 
 
2-2. Preparation of Allenes (1e-g, 1j)  
Preparation of allene 1e 
 
To a 5 mL vial were added K2CO3 (0.15 g, 1.1 mmol), 2-allylphenol (0.15 g, 1.1 mmol), an al-
lene[7,8] (0.25 g, 1.0 mmol), and DMF (0.75 mL). The vial was sealed and stirred at 95 °C for 30 min 
under microwave irradiation. After the mixture was cooled to room temperature, Et2O (5 mL) and H2O 
(5 mL) were added. The organic layer was separated and the aqueous layer was extracted with Et2O (5 
mL × 3). The combined organic layer was dried with Na2SO4, filtered, and then evaporated. The resi-
due was dried with MgSO4, filtered, evaporated, and then dried in vacuo. The crude mixture was pu-
rified by MPLC (eluent: hexane/ethyl acetate = 24:1) to give 1e as a colorless liquid (145 mg, 0.68 
mmol, 68%). 1H NMR (500 MHz, CDCl3) : 7.20–7.13 (m, 2H), 6.92–6.84 (m, 2H), 6.05–5.96 (m, 
1H), 5.10–5.02 (m, 2H), 4.66–4.62 (m, 2H), 4.08 (t, J = 6.7 Hz, 2H), 3.40 (d, J = 6.7 Hz, 2H), 2.47–
2.43 (m, 2H), 1.78 (t, J = 3.1 Hz, 3H). 13C NMR (125 MHz, CDCl3) : 206.42, 156.6, 137.1, 129.7, 
128.9, 127.2, 120.5, 115.2, 111.3, 95.2, 74.5, 66.2, 34.4, 33.2, 19.0. APCI-HRMS (m/z): [M+H]+ calcd 
for C15H19O, 215.1436; found, 215.1430. Anal. Calcd. for C15H18O: C, 84.07; H, 8.47. Found: C, 
83.87; H, 8.32.  
 
Preparation of allene 1f 
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To a 5 mL vial were added K2CO3 (0.23 g, 1.6 mmol), 4-chlorophenol (0.21 g, 1.6 mmol), an allene 
(0.38 g, 1.5 mmol), and DMF (0.75 mL). The vial was sealed and the reaction mixture was stirred at 
95 °C for 30 min under microwave irradiation. After the mixture was cooled to room temperature, 
Et2O (5 mL) and H2O (5 mL) were added. The organic layer was separated and the aqueous layer was 
extracted with Et2O (5 mL × 4). The combined organic layer was dried with Na2SO4, filtered, and then 
evaporated. The residue was dried with MgSO4, filtered, evaporated, and then dried in vacuo. The 
crude mixture was purified by MPLC (eluent: hexane/ethyl acetate = 49:1) to give 1f as a colorless 
liquid (225 mg, 1.1 mmol, 72%). 1H NMR (500 MHz, CDCl3) : 7.22 (d, J = 8.9 Hz, 2H), 6.82 (d, J 
= 8.9 Hz, 2H), 4.66–4.61 (m, 2H), 4.03 (t, J = 6.9 Hz, 2H), 2.43–2.38 (m, 2H), 1.76 (t, J = 3.2 Hz, 3H). 
13C NMR (125 MHz, CDCl3) : 206.2, 157.6, 129.3, 125.5, 115.9, 95.0, 74.9, 66.6, 32.8, 19.1. APCI-
HRMS (m/z): [M+H]+ calcd for C12H14ClO, 209.0733; found, 209.0724. Anal. Calcd. for C12H13ClO: 
C, 69.07; H, 6.28. Found: C, 68.93; H, 6.37. 
 
Preparation of allene 1g 
 
To a 5 mL vial were added K2CO3 (0.25 g, 1.8 mmol), 4-iodophenol (0.36 g, 1.6 mmol), an allene 
(0.38 g, 1.5 mmol), and DMF (0.75 mL). The vial was sealed and the reaction mixture was stirred at 
95 °C for 30 min under microwave irradiation. After the mixture was cooled to room temperature, 
Et2O (5 mL) and H2O (5 mL) were added. After the organic layer was separated and the aqueous layer 
was extracted with Et2O (5 mL × 3). The combined organic layer was dried with MgSO4, filtered, and 
then evaporated. The residue was dried with MgSO4, filtered, evaporated, and then dried in vacuo. The 
crude mixture was purified by MPLC (eluent: hexane/ethyl acetate = 19:1) to give 1g as a colorless 
liquid (346 mg, 1.2 mmol, 77%). 1H NMR (500 MHz, CDCl3) : 7.54 (dt, J = 9.3, 2.6 Hz, 2H), 6.68 
(dt, J = 9.3, 2.6 Hz, 2H), 4.66–4.62 (m, 2H), 4.03 (t, J = 6.9 Hz, 2H), 2.43–2.37 (m, 2H), 1.76 (t, J = 
3.2 Hz, 3H). 13C NMR (125 MHz, CDCl3) : 206.1, 158.8, 138.1, 117.0, 94.9, 82.6, 74.9, 66.3, 32.7, 
19.1. APCI-HRMS (m/z): [M+H]+ calcd for C12H14IO, 301.0089; found, 301.0076. Anal. Calcd. for 
C12H13IO: C, 48.02; H, 4.37. Found: C, 48.22; H, 4.41.  
 
Preparation of allene 1j 
 
To a 20 mL Schlenk tube were added CH2Cl2 solution (1 mL) of an allenol (0.29 g, 3.0 mmol), 
N,N-dimethylaminopyridine (DMAP, 18 mg, 0.15 mmol), pyridine (0.48 mL, 6.0 mmol), and CH2Cl2 
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(8 mL). After the mixture was cooled to 0 °C, 3,3-dimethylbutanoyl chloride (0.62 mL, 4.5 mmol) was 
added dropwise with syringe. The reaction mixture was stirred at 0 °C to room temperature for 15 h. 
The resulting solution was washed with 1 M HCl aq. (10 mL and 5 mL), saturated NaHCO3 aq. (5mL 
× 2), and brine (5 mL). The organic layer was dried with Na2SO4, filtered, evaporated, and then dried 
in vacuo. The crude mixture was purified by MPLC twice (eluent: hexane/ethyl acetate =19:1 and 
24:1) to give 1j as colorless liquid (0.30 g, 1.5 mmol, 51%). 1H NMR (500 MHz, CDCl3) : 4.63–4.58 
(m, 2H), 4.15 (t, J = 6.9 Hz, 2H), 2.28–2.23 (m, 2H), 2.18 (s, 2H), 1.70 (t, J = 3.1 Hz, 3H), 1.01 (s, 
9H). 13C NMR (125 MHz, CDCl3) : 206.2, 172.3, 94.7, 74.8, 62.0, 48.0, 32.5, 30.6, 29.6, 18.7. APCI-
HRMS (m/z): [M+H]+ calcd for C12H21O2, 197.1536; found, 197.1535. Anal. Calcd. for C12H20O2: C, 
73.43; H, 10.27. Found: C, 73.20; H, 10.18. 
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3.  Experimental Procedures 
 
3.1. Optimization of Reaction Condition of Boraformylation of 1a (Table 1) 
To a Schlenk tube filled with Ar was added CuOAc (1.1 mg, 9.0 mol) and ligand (12 mol). The 
tube was dried, then evacuated and backfilled with Ar three times. In the case of IPrCuCl or IMesCuCl, 
the complex (9.0 mol) and tBuOK (1M THF solution, 30 mol) was added. Toluene (0.25 mL), 3-
methyl-1,2-nonadiene (1a, 55 L, 0.30 mmol), and hexyl formate (49 L, 0.33 mmol) were added to 
the Schlenk tube in this order. Then, a solution B2(pin)2 (91 mg, 0.36 mmol) in toluene (0.20 mL) in a 
Spitz tube was added to the Schlenk tube. The system was closed, and the mixture was stirred at 50 °C 
for 6 h. After tridecane (50 L) was added as an internal standard, the resulting mixture was diluted 
with Et2O (10 mL), and then an aliquot of the organic phase was filtered through a pad of Celite
®. The 
filtrate was analyzed by GC. 
 
3.2. A Procedure for Boraformylation of Allene (1) (Table 2) 
To a Schlenk tube filled with Ar was added CuOAc (1.1 mg, 9.0 mol) and DTBM-dppbz (12 mg, 
12 mol). In the case of entries 5–11, C11H23CO2K (14 mg, 60 mol) was also added. The tube was 
dried, then evacuated and backfilled with Ar three times. Toluene (0.25 mL), allene (1, 0.30 mmol), 
and hexyl formate (49 L, 0.33 mmol) were added to the Schlenk tube in this order. Then, a solution 
B2(pin)2 (91 mg, 0.36 mmol) in toluene (0.20 mL) in a Spitz tube was added to the Schlenk tube. The 
system was closed, and the mixture was stirred at 50 °C for 6 h. The resulting mixture was diluted with 
Et2O (10 mL) and filtered through a pad of Celite
®. The filtrate was evaporated and then dried in vacuo. 
The residue was purified by B-silica-gel column chromatography.  
 
3.3. A Procedure of Pd-catalyzed Suzuki-Miyaura Coupling of 2a with an Aryl Iodide (Scheme 
2b) 
To a Schlenk tube filled with Ar was added PdCl2(PhCN)2 (3.8 mg, 10 mol) and DTBPF (4.7 mg, 
10 mol). The tube was dried, then evacuated and backfilled with Ar three times. THF (0.40 mL) and 
2a (29 mg, 0.10 mmol) were added, then the mixture was stirred at room temperature for 30 min. 
TBAF (172 L, 0.60 mmol), H2O (40 L), and 1-tert-butyl-4-iodobenzene (26 L, 0.15 mmol) were 
added in this order. The system was closed, and the mixture was stirred at 50 °C for 19 h. The resulting 
mixture was diluted with Et2O (10 mL) and filtered through a pad of Celite
®. The filtrate was evapo-
rated and dried in vacuo. The residue was purified by silica-gel column chromatography.  
 
3.4. A Procedure of Pd-catalyzed Suzuki-Miyaura Coupling of 2a with an Alkenyl Bromide 
(Scheme 2c) 
To a Schlenk tube filled with Ar was added PdCl2(PhCN)2 (3.8 mg, 10 mol) and DTBPF (4.7 mg, 
10 mol). The tube was dried, then evacuated and backfilled with Ar three times. THF (0.40 mL) and 
2a (29 mg, 0.10 mmol) were added, then the mixture was stirred at room temperature for 30 min. 
TBAF (172 L, 0.60 mmol), H2O (40 L), and -bromostyrene (19 L, 0.15 mmol) were added in this 
order. The system was closed, and the mixture was stirred at 50 °C for 19 h. The resulting mixture was 
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diluted with Et2O (10 mL) and filtered through a pad of Celite
®. The filtrate was evaporated and dried 
in vacuo. The residue was purified by silica-gel column chromatography.   
 
3.5. Horner-Wadsworth-Emmons Olefination of 2a (Scheme 2d)   
The Schlenk tube was dried, then evacuated and backfilled with Ar three times. After tBuOK (1.0 
M in THF, 0.12 mL) was added, the solution was cooled to 0 ºC. Trimethyl phosphonoacetate (17 L, 
0.12 mmol) was added, and then stirred for 15 min at 0 ºC. After THF (0.18 mL) and 2a (29 mg, 0.10 
mmol) were added, then the system was closed, and the mixture was stirred at 0 ºC to RT for 22 h. The 
resulting mixture was diluted with Et2O (10 mL) and filtered through a pad of Celite
®. The filtrate was 
evaporated and then dried in vacuo. The residue was purified by B-silica-gel column chromatography. 
 
3.6. A Procedure of the reaction for eq 1   
To a Schlenk tube filled with Ar was added CuOAc (1.1 mg, 9.0 mol) and DTBM-dppbz (12 mg, 
12 mol). The tube was dried, then evacuated and backfilled with CO. Toluene (0.25 mL), 1a (0.30 
mmol), and hexanol (41 L, 0.33 mmol) were added to the Schlenk tube in this order. Then, a solution 
B2(pin)2 (91 mg, 0.36 mmol) in toluene (0.20 mL) in a Spitz tube was added to the Schlenk tube. The 
system was closed, and the mixture was stirred at 50 °C for 6 h. After tridecane (50 L) was added as 
an internal standard, the resulting mixture was diluted with Et2O (10 mL), and then an aliquot of the 
organic phase was filtered through a pad of Celite®. The filtrate was analyzed by GC. 
 
3.7. General Procedure for Silaformylation of 1b (Scheme 3) 
To a Schlenk tube filled with Ar was added CuOAc (1.0 mg, 8.0 mol) and ligand (10 mol). The 
tube was dried, then evacuated and backfilled with Ar three times. THF (0.20 mL), 1,1-pentameth-
yleneallene (1b) (26 L, 0.20 mmol), hexyl formate (32 L, 0.22 mmol) and PhMe2Si–B(pin) (66 L, 
0.24 mmol) were added in this order. The system was closed, and the mixture was stirred at 60 °C for 
4 h. After tridecane (50 L) was added as an internal standard, the resulting mixture was diluted with 
hexane (10 mL), and then an aliquot of the organic phase was filtered through a pad of Celite®. The 
filtrate was analyzed by GC. 
 
3.8. A Procedure for the Cu-Catalyzed Silaformylation of allene (1) (Scheme 4) 
To a Schlenk tube filled with Ar were added CuOAc (1.0 mg, 8.0 mol) and DTBM-dppbz (10 mg, 
10 mol). The tube was dried, then evacuated and backfilled with Ar three times. THF (0.20 mL), 
allene (1) (0.20 mmol), hexyl formate (32 L, 0.22 mmol) and PhMe2Si–B(pin) (66 L, 0.24 mmol) 
were added in this order. The system was closed, and the mixture was stirred at 60 °C for 4 h. After 
tridecane (50 L) was added as an internal standard, the resulting mixture was diluted with hexane (10 
mL), and then an aliquot of the organic phase was filtered through a pad of Celite®. The residue was 
purified by silica-gel column chromatography.   
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4.  Characterization of Products 
 
Purified by B-silica-gel column chromatography (eluent: hexane/CH2Cl2/ace-
tone = 150:10:1). Pale yellow oil (77 mg, 87%). 1H NMR (500 MHz, CDCl3) δ: 
9.55 (s, 1H), 6.02 (d, J = 2.1 Hz, 1H), 5.65 (d, J = 2.1 Hz, 1H), 1.85–1.79 (m, 1H), 
1.64–1.58 (m, 1H), 1.29–1.24 (m, 18H), 1.17–1.11 (m, 5H), 0.86 (t, J = 6.9 Hz, 3H). 
13C NMR (125 MHz, CDCl3) δ: 204.8, 130.3, 83.6, 54.5, 34.5, 31.6, 29.9, 24.7, 
24.6, 23.9, 22.6, 18.2, 14.0. ESI-HRMS (m/z): [M+H]+ calcd for C17H32BO3, 295.2445; found, 
295.2434. 
 
Purified by B-silica-gel column chromatography (eluent: hexane/CH2Cl2/acetone = 
150:10:1). Yellow oil (67 mg, 84%). 1H NMR (500 MHz, CDCl3) δ: 9.47 (s, 1H), 6.00 
(s, 1H), 5.67 (s, 1H), 2.03–1.98 (m, 2H), 1.67–1.61 (m, 2H), 1.58–1.45 (m, 3H), 1.41–
1.32 (m, 2H), 1.30–1.21 (m, 13H). 13C NMR (125 MHz, CDCl3) δ: 204.5, 130.7, 83.6, 
54.9, 30.3, 25.7, 24.6, 22.6. APCI-HRMS (m/z): [M+H]+ calcd for C15H25BO3, 
265.1975; found, 265.1965.  
 
Purified by B-silica-gel column chromatography (eluent: hexane/CH2Cl2/acetone 
= 150:10:1). Colorless oil (59 mg, 64%). 1H NMR (500 MHz, CDCl3) δ: 9.49 (s, 
1H), 6.07 (d, J = 2.1 Hz, 1H), 5.66 (d, J = 2.1 Hz, 1H), 1.75–1.65 (m, 4H), 1.32–
1.23 (m, 16H), 1.16–1.05 (m, 4H), 0.87 (t, J = 7.5 Hz, 6H). 13C NMR (125 MHz, 
CDCl3) δ: 205.2, 130.7, 83.5, 57.4, 31.5, 26.0, 24.6, 23.4, 13.9. APCI-HRMS 
(m/z): [M+H]+ calcd for C18H34BO3, 309.2601; found, 309.2586.  
 
Purified by B-silica-gel column chromatography three times (eluent: hex-
ane/CH2Cl2/acetone = 100:10:1, hexane/CH2Cl2 = 3:1, and hexane/CH2Cl2 = 5:1). 
White solid (41 mg, 46%). 1H NMR (500 MHz, CDCl3) δ: 9.73 (s, 1H), 6.03 (d, J 
= 1.5 Hz, 1H), 5.64 (d, J = 1.5 Hz, 1H), 2.22 (tt, J = 12.2, 3.1 Hz, 1H), 1.78–1.73 
(m, 2H), 1.68–1.63 (m, 1H), 1.54–1.50 (m, 1H), 1.30–1.20 (m, 16H), 1.08 (s, 3H), 
0.87 (dq, J = 12.5, 3.1 Hz, 1H). 13C NMR (125 MHz, CDCl3) δ: 205.4, 131.0, 83.7, 58.5, 41.1, 28.7, 
27.3, 27.0, 27.0, 26.5, 24.8, 24.5, 13.2. APCI-HRMS (m/z): [M+H]+ calcd for C17H30BO3, 293.2288; 
found, 293.2278. 
 
Purified by B-silica-gel column chromatography three times (eluent: hex-
ane/CH2Cl2 = 6:1, hexane/CH2Cl2/acetone = 90:10:1, and hexane/CH2Cl2 = 3:1). 
Yellow oil (86 mg, 78%). 1H NMR (500 MHz, CDCl3) δ: 9.62 (s, 1H), 7.16–
7.11 (m, 2H), 6.87 (dt, J = 7.3, 0.9 Hz, 1H), 6.79 (d, J = 8.2 Hz, 1H), 6.07 (d, J 
= 1.5 Hz, 1H), 5.98 (ddt, J = 16.8, 10.1, 6.7 Hz,1H), 5.73 (d, J = 1.5 Hz, 1H), 
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5.07–5.01 (m, 2H), 3.98–3.93 (m, 2H), 3.37–3.34 (m, 2H), 2.30 (t, J = 6.6 Hz, 2H), 1.30 (s, 3H), 1.25 
(d, J = 1.5 Hz, 12H). 13C NMR (125 MHz, CDCl3) δ: 203.5, 156.3, 137.0, 130.7, 129.7, 128.7, 127.2, 
120.5, 115.3, 111.1, 83.8, 64.3, 53.2, 34.3, 34.3, 24.7, 24.6, 18.8. APCI-HRMS (m/z): [M+H]+ calcd 
for C22H32BO4, 371.2394; found, 371.2379.  
 
Purified by B-silica-gel column chromatography (eluent: hexane/CH2Cl2/ace-
tone = 90:10:1). White solid (80 mg, 74%). 1H NMR (500 MHz, CDCl3) δ: 9.58 
(s, 1H), 7.19 (d, J = 8.9 Hz, 2H), 6.77 (d, J = 8.9 Hz, 2H), 6.05 (s, 1H), 5.69 (s, 
1H), 3.98–3.87 (m, 2H), 2.32–2.19 (m, 2H), 1.26 (s, 3H), 1.24 (s, 12H). 13C 
NMR (125 MHz, CDCl3) δ: 203.3, 157.2, 130.5, 129.2, 125.5, 115.8, 83.8, 64.6, 53.0, 34.0, 24.6, 24.6, 
18.7. APCI-HRMS (m/z): [M+H]+ calcd for C19H27BClO4, 365.1691; found, 365.1680. 
 
Purified by B-silica-gel column chromatography twice (eluent: hex-
ane/CH2Cl2/acetone = 90:10:1 and hexane/CH2Cl2 = 3:1).White solid (71 mg, 
52%). 1H NMR (500 MHz, CDCl3) δ: 9.58 (s, 1H), 7.52 (d, J = 8.6 Hz, 2H), 
6.63 (d, J = 8.6 Hz, 2H), 6.05 (d, J = 1.4 Hz, 1H), 5.70 (d, J = 1.4 Hz, 1H), 3.97–
3.88 (m, 2H), 2.34–2.18 (m, 2H), 1.27 (s, 3H), 1.25 (s, 12H). 13C NMR (125 MHz, CDCl3) δ: 203.2, 
158.5, 138.1, 130.5, 116.9, 83.8, 82.7, 64.4, 53.0, 33.9, 24.6, 24.6, 18.7. APCI-HRMS (m/z): [M+H]+ 
calcd for C19H27BIO4, 457.1047; found, 457.1033. 
 
Purified by B-silica-gel column chromatography three times (eluent: hex-
ane/CH2Cl2/acetone = 100:10:1, hexane/CH2Cl2/acetone = 150:10:1, and hex-
ane/CH2Cl2 = 6:1). Colorless oil (81 mg, 73%). 1H NMR (400 MHz, CDCl3) δ: 
9.57 (s, 1H), 5.99 (d, J = 1.8 Hz, 1H), 5.65 (d, J = 1.8 Hz, 1H), 3.65-3.55 (m, 2H), 
2.18-2.04 (m, 1H), 2.00-1.90 (m, 1H), 1.25 (s, 12H), 1.22 (s, 3H), 0.87 (s, 9H), 0.02 
(s, 3H), 0.02 (s, 3H). 13C NMR (100 MHz, CDCl3) δ: 204.0, 129.8, 83.7, 59.4, 53.0, 37.9, 25.9, 24.7, 
24.6, 18.4, 18.2, -5.4, -5.5. ESI-HRMS (m/z): [M+H]+ calcd for C19H37BO4Si, 391.2452; found, 
391.2435. 
 
Purified by B-silica-gel column chromatography (eluent: hexane/CH2Cl2/ace-
tone = 60:10:1). Yellow oil (87 mg, 90%). 1H NMR (500 MHz, CDCl3) δ: 9.51 (s, 
1H), 6.09 (s, 1H), 5.77 (s, 1H), 3.92 (s, 4H), 2.19–2.13 (m, 2H), 1.95–1.88 (m, 2H), 
1.71–1.58 (m, 4H), 1.25 (s, 12H). 13C NMR (125 MHz, CDCl3) δ: 203.3, 131.8, 
108.4, 83.7, 64.2, 64.2, 54.0, 31.3, 27.4, 24.6, 24.6. APCI-HRMS (m/z): [M+H]+ 
calcd for C17H28BO5, 323.2030; found, 323.2018. 
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Purified by B-silica-gel column chromatography twice (eluent: hex-
ane/CH2Cl2/acetone = 30:10:1 and hexane/CH2Cl2/acetone = 80:10:1). Colorless 
oil (59 mg, 56%). 1H NMR (500 MHz, CDCl3) δ: 9.52 (s, 1H), 6.07 (s, 1H), 5.70 
(s, 1H), 4.09–3.96 (m, 2H), 2.22–2.16 (m, 1H), 2.15 (s, 2H), 2.09–2.02 (m, 1H), 
1.25 (s, 12H), 1.23 (s, 3H), 1.01 (s, 9H).13C NMR (125 MHz, CDCl3) δ: 203.2, 172.1, 131.1, 83.8, 
60.5, 53.0, 47.8, 33.1, 30.7, 29.6, 24.7, 24.6, 18.3. MALDI-HRMS (m/z): [M+Na]+ calcd for 
C19H33BNaO5, 375.23187; found, 375.23089. 
 
Purified by B-silica-gel column chromatography (eluent: eluent: hex-
ane/CH2Cl2/acetone = 60:10:1). Pale yellow solid (49 mg, 45%). 1H NMR 
(400 MHz, CDCl3) δ: 9.52 (s, 1H), 6.12 (d, J = 1.4 Hz, 1H), 5.73 (d, J = 1.4 
Hz, 1H), 3.79–3.62 (m, 2H), 3.10 (t, J = 11.1 Hz, 2H), 2.12 (dt, J = 13.6, 3.6 
Hz, 2H), 1.85–1.73 (m, 2H), 1.44 (s, 9H), 1.25 (s, 12H). 13C NMR (100 MHz, 
CDCl3) δ: 203.0, 154.8, 132.2, 83.9, 79.5, 77.2, 53.5, 29.5, 29.5, 28.4, 24.6. EI-HRMS (m/z): [M+H]+ 
calcd for C19H32BNO5, 365.2374; found, 365.2368.  
 
Purified by silica-gel column chromatography (eluent: hexane/Et2O = 30:1). Pale yellow 
oil (23 mg, 83 mol, 83%). 1H NMR (500 MHz, CDCl3) : 9.53 (s, 1H), 7.30 (d, J = 8.5 
Hz ,2H), 7.03 (d, J = 8.5 Hz ,2H), 5.29 (s, 1H), 5.23 (s, 1H), 1.72–1.59 (m, 2H), 1.31 (s, 
9H), 1.28–1.17 (m, 11H), 0.85 (t, J = 6.7 Hz ,3H). 13C NMR (125 MHz, CDCl3) : 203.4, 
150.1, 149.9, 138.4, 127.6, 124.8, 117.6, 55.6, 34.4, 34.0, 31.6, 31.3, 29.7, 23.8, 22.5, 
18.9, 14.0. APCI-HRMS (m/z): [M+H]+ calcd for C21H33O, 301.2531; found, 301.2517.  
 
Purified by silica-gel column chromatography (eluent: hexane/Et2O = 30:1). Yellow oil 
(16 mg, 58 mol, 58%). 1H NMR (500 MHz, CDCl3) δ: 9.45 (s, 1H), 7.41–7.35 (m, 
2H), 7.35–7.28 (m, 2H), 7.25–7.22 (m, 1H), 6.73 (d, J = 15.9 Hz, 1H), 6.57 (d, J = 15.9 
Hz, 1H), 5.55 (s, 1H), 5.05 (s, 1H), 1.84–1.74 (m, 1H), 1.72–1.61 (m, 1H), 1.34–1.13 
(m, 11H), 0.85 (t, J = 6.7 Hz, 3H). 13C NMR (125 MHz, CDCl3) : 203.5, 146.1, 136.9, 
130.8, 128.6, 127.8, 127.5, 126.6, 114.4, 54.6, 33.7, 31.6, 29.8, 23.6, 22.6, 18.3, 14.0. 
APCI-HRMS (m/z): [M+H]+ calcd for C19H27O, 271.2062; found, 271.2048.  
 
Purified by B-silica-gel column chromatography (eluent: hexane/CH2Cl2/acetone = 
120:10:1).Colorless oil (25 mg, 71 mol, 71%). 1H NMR (500 MHz, CDCl3) : 7.15 
(d, J = 15.9 Hz, 1H), 5.84 (d, J = 2.3 Hz, 1H), 5.72 (d, J = 15.9 Hz, 1H), 5.53 (d, J = 
2.3 Hz, 1H), 3.72 (s, 3H), 1.75–1.64 (m, 1H), 1.62–1.52 (m, 1H), 1.24 (s, 20H), 1.20 
(s, 3H), 0.86 (t, J = 6.8 Hz, 3H). 13C NMR (125 MHz, CDCl3) : 167.6, 157.3, 128.1, 
117.9, 83.3, 51.3, 44.8, 39.2, 31.7, 29.9, 29.6, 24.7, 24.6, 24.5, 22.8, 22.6, 14.1. APCI-HRMS (m/z): 
[M+H]+ calcd for C20H36BO4, 351.2707; found, 351.2692. 
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Purified by column chromatography (eluent: hexane/CH2Cl2/acetone = 200:10:3). 
Colorless oil (54 mg, 88%). 1H NMR (400 MHz, CDCl3) : 9.28 (s, 1H), 7.51–
7.50 (m, 2H), 7.36–7.34 (m, 3H), 5.81 (d, J = 1.4 Hz, 1H), 5.78 (d, J = 1.4 Hz, 
1H), 1.64–1.55 (m, 2H), 1.31–0.97 (m, 11H), 0.86 (t, J = 7.0 Hz, 3H), 0.43 (s, 6H). 
13C NMR (100 MHz, CDCl3) : 203.4, 150.4, 138.5, 133.8, 130.6, 129.0, 127.8, 
56.5, 35.0, 31.6, 29.7, 23.9, 22.5, 19.1, 14.0, –0.7, –0.8. 29Si NMR (99 MHz, CDCl3) : –7.7. IR 
(ATR): 733.0, 775.4, 819.8, 835.2, 939.3, 1111.0, 1249.9, 1427.3, 1726.3, 2856.6, 2929.9, 2955.0. 
MALDI-HRMS (m/z): [M+Na]+ calcd for C19H30OSiNa, 325.1958; found, 325.1962. 
 
Purified by column chromatography (eluent: hexane/CH2Cl2/acetone = 
200:10:3). White opaque oil (47 mg, 86%). 1H NMR (500 MHz, CDCl3) :9.16 (s, 
1H), 7.50–7.49 (m, 2H), 7.36–7.35 (m, 3H), 5.82 (s, 1H), 5.74 (s, 1H), 2.02–1.99 (m, 
2H), 1.51–1.49 (m, 5H), 1.26–1.24 (m, 2H), 1.10–1.07 (m, 1H), 0.43 (s, 6H). 13C 
NMR (125 MHz, CDCl3) : 203.0, 150.2, 138.7, 133.8, 131.3, 129.0, 127.8, 57.2, 
31.6, 25.4, 22.9, –0.5. 29Si NMR (99 MHz, CDCl3) : –7.3. IR (ATR): 733.0, 777.3, 817.8, 833.3, 
906.5, 943.2, 1109.1, 1249.9, 1427.3, 1448.5, 1724.4, 2854.7, 2933.7. ESI-HRMS (m/z): [M+Na]+ 
calcd for C17H24OSiNa, 295.1489; found, 295.1490. 
 
Purified by column chromatography (eluent: hexane/CH2Cl2/acetone = 
200:10:3). Colorless oil (54 mg, 87%). 1H NMR (500 MHz, CDCl3) : 9.24 (s, 
1H), 7.53–7.49 (m, 2H), 7.37–7.32 (m, 3H), 5.85 (d, J = 1.2 Hz, 1H), 5.82 (d, J = 
1.2 Hz, 1H), 1.65–1.57 (m, 4H), 1.22–0.87 (m, 8H), 0.82 (t, J = 7.3 Hz, 6H), 0.42 
(s, 6H). 13C NMR (125 MHz, CDCl3) : 203.8, 149.5, 138.6, 133.8, 131.2, 129.0, 
127.7, 59.8, 31.3, 25.9, 23.1, 13.9, –0.7. 29Si NMR (99 MHz, CDCl3) : –7.8. IR (ATR): 733.0, 775.4, 
819.8, 835.2, 939.3, 1109.1, 1249.9, 1379.1, 1427.3, 1724.4, 2931.8, 2956.9. ESI-HRMS (m/z): 
[M+Na]+ calcd for C20H32OSiNa, 339.2115; found, 339.2112. 
 
Purified by column chromatography twice (eluent: hexane/CH2Cl2/acetone = 
100:5:1, and hexane/CH2Cl2 = 5:1). Colorless oil (41 mg, 68%). 1H NMR (500 
MHz, CDCl3) : 9.33 (s, 1H), 7.51–7.44 (m, 2H), 7.38–7.31 (m, 3H), 5.91 (s, 1H), 
5.85 (s, 1H), 1.95–1.86 (m, 1H), 1.76–1.55 (m, 4H), 1.45–1.38 (m, 1H), 1.28–0.96 
(m, 7H), 0.89–0.79 (m, 1H), 0.43 (s, 6H). 13C NMR (125 MHz, CDCl3) : 203.6, 149.8, 138.7, 133.8, 
131.2, 129.0, 127.8, 60.0, 42.0, 28.6, 26.8, 26.8, 26.7, 26.5, 14.3, –0.4, –0.6. 29Si NMR (99 MHz, 
CDCl3) : –7.4. IR (ATR): 702.1, 734.9, 777.3, 819.8, 835.2, 906.5, 937.4, 1109.1, 1249.9, 1427.3, 
1450.5, 1722.4, 2852.7, 2927.9. MALDI-HRMS (m/z): [M+Na]+ calcd for C19H28OSiNa, 323.1802; 
found, 323.1808. 
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Purified by column chromatography (eluent: hexane/CH2Cl2/acetone = 
200:10:3). Colorless oil (61 mg, 81%). 1H NMR (500 MHz, CDCl3) : 9.33 (s, 
1H), 7.51-7.49 (m, 2H), 7.35-7.32 (m, 3H), 7.15-7.09 (m, 2H), 6.87 (dd, J = 7.6, 
7.6 Hz, 1H), 6.68 (d, J = 7.6 Hz, 1H), 5.98-5.89 (m, 1H), 5.87 (s, 1H), 5.84 (s, 
1H), 5.04-5.02 (m, 1H), 5.00 (s, 1H), 3.80 (t, J = 6.6 Hz, 2H), 3.35-3.25 (m, 2H), 2.24-2.17 (m, 1H), 
2.12-2.06 (m, 1H), 1.23 (s, 3H), 0.45 (s, 6H). 13C NMR (125 MHz, CDCl3) : 202.0, 156.2, 150.0, 
138.1, 136.9, 133.8, 131.3, 129.7, 129.2, 128.6, 127.9, 127.1, 120.5, 115.3, 110.9, 64.0, 55.1, 34.8, 
34.2, 19.6, -0.8, -0.9. 29Si NMR (99 MHz, CDCl3) : –7.4. IR (ATR): 702.1, 734.9, 750.3, 777.3, 
817.8, 835.2, 912.3, 943.2, 997.2, 1022.3, 1047.4, 1109.1, 1240.2, 1427.3, 1454.3, 1475.5, 1492.9, 
1600.9, 1724.4. ESI-HRMS (m/z): [M+Na]+ calcd for C24H30O2SiNa, 401.1907; found, 401.1902. 
Anal. Calcd. for C24H30O2Si: C, 76.14; H, 7.99. Found: C, 76.23; H, 7.97. 
 
Purified by column chromatography twice (eluent: hexane/CH2Cl2/ace-
tone = 200:10:3). White solid (51 mg, 68%). 1H NMR (500 MHz, CDCl3) 
: 9.31 (s, 1H), 7.50–7.48 (m, 2H), 7.35–7.33 (m, 3H), 7.18 (d, J = 9.2 Hz, 
2H), 6.69 (d, J = 9.2 Hz, 2H), 5.84 (s, 1H), 5.83 (s, 1H), 3.81–3.72 (m, 2H), 
2.20–2.14 (m, 1H), 2.08–2.02 (m, 1H), 1.20 (s, 3H), 0.45 (s, 3H), 0.44 (s, 3H). 13C NMR (125 MHz, 
CDCl3) : 201.9, 157.1, 149.8, 138.1, 133.8, 131.3, 129.2, 129.2, 127.9, 125.5, 115.6, 64.4, 55.0, 34.4, 
19.6, –0.8, –0.9. 29Si NMR (99 MHz, CDCl3) : –7.4. IR (ATR): 704.0, 733.0, 771.5, 785.0, 819.8, 
827.5, 902.7, 950.9, 1018.4, 1030.0, 1087.9, 1109.1, 1246.0, 1290.4, 1469.8, 1494.8, 1712.8. APCI-
HRMS (m/z): [M+H]+ calcd for C21H26ClO2Si, 373.1358; found, 373.1378. 
 
Purified by column chromatography three times (eluent: hexane/CH2Cl2/ace-
tone = 200:10:3, hexane/CH2Cl2 = 5:1 to hexane/CH2Cl2/acetone = 50:10:3, 
and hexane/CH2Cl2 = 5:1). White solid (32 mg, 34%). 1H NMR (500 MHz, 
CDCl3) : 9.31 (s, 1H), 7.52–7.47 (m, 4H), 7.36–7.32 (m, 3H), 6.54 (d, J = 
8.9 Hz, 2H), 5.84 (s, 1H), 5.83 (s, 1H), 3.80–3.70 (m, 2H), 2.19–2.13 (m, 1H), 2.08–2.02 (m, 1H), 1.19 
(s, 3H), 0.45 (s, 3H), 0.44 (s, 3H). 13C NMR (125 MHz, CDCl3) : 201.9, 158.3, 149.8, 138.1, 138.1, 
133.8, 131.3, 129.3, 127.9, 116.8, 82.7, 64.2, 55.0, 34.4, 19.6, –0.8, –0.9. 29Si NMR (99 MHz, CDCl3) 
: –7.4. IR (ATR): 702.1, 734.9, 777.3, 817.8, 835.2, 943.2, 999.1, 1020.3, 1058.9, 1111.0, 1174.7, 
1242.2, 1280.7, 1400.3, 1427.3, 1475.5, 1485.2, 1585.5, 1722.4. ESI-HRMS (m/z): [M+Na]+ calcd 
for C21H25IO2SiNa, 487.0561; found, 478.0554. 
 
 
Purified by column chromatography (eluent: eluent: hexane/CH2Cl2/acetone 
= 100:10:3). Colorless oil (51.2 mg, 77%). 1H NMR (500 MHz, CDCl3) : 9.17 
(s, 1H), 7.52–7.44 (m, 2H), 7.39–7.29 (m, 3H), 5.83 (s, 1H), 5.75 (s, 1H), 3.88 (s, 
4H), 2.08–1.95 (m, 2H), 1.88–1.77 (m, 2H), 1.62–1.53 (m, 2H), 1.52–1.42 (m, 2H), 
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0.44 (s, 6H). 13C NMR (125 MHz, CDCl3) : 202.1, 148.9, 138.3, 133.8, 131.7, 129.1, 127.8, 108.0, 
64.2, 64.2, 56.2, 31.5, 28.5, –0.7. 29Si NMR (99 MHz, CDCl3) : –7.1. IR (ATR): 731.0, 779.2, 821.7, 
875.7, 945.1, 997.2, 1033.9, 1109.1, 1251.8, 1369.5, 1427.3, 1720.5, 2955.0. ESI-HRMS (m/z): 
[M+Na]+ calcd for C19H26O3SiNa, 353.1543; found, 353.1538. 
 
Purified by column chromatography twice (eluent: eluent: hex-
ane/CH2Cl2/acetone = 60:10:3, and eluent: hexane/CH2Cl2/acetone = 100:10:3). 
Colorless oil (50.6 mg, 70%). 1H NMR (500 MHz, CDCl3) : 9.24 (s, 1H), 
7.51–7.47 (m, 2H), 7.37–7.33 (m, 3H), 5.83 (s, 1H), 5.82 (s, 1H), 3.92 (t, J = 
7.3 Hz, 2H), 2.12 (s, 2H), 2.01–1.91 (m, 2H), 1.17 (s, 3H), 0.99 (s, 9H), 0.44 (s, 3H), 0.43 (s, 3H). 13C 
NMR (125 MHz, CDCl3) : 201.7, 172.0, 149.4, 137.9, 133.8, 131.4, 129.2, 127.9, 60.3, 54.9, 47.8, 
33.5, 30.6, 29.6, 19.3, –0.8, –0.9. 29Si NMR (99 MHz, CDCl3) : –7.4. IR (ATR): 702.1, 734.9, 777.3, 
819.8, 835.2, 943.2, 999.1, 1111.0, 1130.3, 1228.7, 1249.9, 1323.2, 1367.5, 1429.3, 1465.9, 1728.2, 
2958.8. ESI-HRMS (m/z): [M+Na]+ calcd for C21H32O3SiNa, 383.2013; found, 383.2005. Anal. Calcd. 
for C21H32O3Si: C, 69.95; H, 8.95. Found: C, 70.00; H, 8.96. 
  
Purified by column chromatography three times (eluent: hexane/CH2Cl2/acetone = 
200:10:3, hexane/acetone = 100:1, and hexane/CH2Cl2 = 5:1). Colorless oil (29 mg, 
53%). 1H NMR (500 MHz, CDCl3) : 9.58 (d, J = 4.7 Hz, 1H), 7.55–7.44 (m, 2H), 
7.41–7.29 (m, 3H), 6.05 (s, 1H), 5.88 (s, 1H), 2.97 (d, J = 4.7 Hz, 1H), 1.42–1.30 
(m, 1H), 1.29–1.18 (m, 1H), 0.96 (s, 3H), 0.82 (s, 3H), 0.75 (t, J = 7.5 Hz, 3H), 
0.40 (s, 3H), 0.39 (s, 3H). 13C NMR (125 MHz, CDCl3) : 202.1, 144.8, 137.0, 134.1, 132.4, 129.3, 
127.8, 63.0, 37.9, 33.6, 24.6, 8.0, –2.8, –2.9. 29Si NMR (99 MHz, CDCl3) : –6.0. IR (ATR): 734.9, 
777.3, 817.8, 833.3, 941.3, 1111.0, 1249.9, 1427.3, 1716.7, 2964.6. APCI-HRMS (m/z): [M+Na]+ 
calcd for C17H26OSiNa, 297.1645; found, 297.1639. 
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